Amgen is committed to protecting the rights of clinical trial participants worldwide.
Amgentrials.com offers patients, investigators and the public easily accessible information about Amgen-sponsored clinical trials, including enrollment information for actively recruiting studies and results summaries for completed ones.
Amgen is a science-based company. As an innovator of life-saving medicines for grievous illness, our mission is to serve patients. We are also committed to a variety of data-sharing initiatives set forth in the Principles for Responsible Clinical Trial Data Sharing
Amgen is committed to the highest scientific and ethical standards for publications, and is dedicated to providing scientifically accurate, fair, and well-balanced publications to the scientific community.
The purpose of this policy is to set forth the Amgen Biobanking of Human Samples collected during the course of research studies.
An Adverse Event (or Adverse Experience, or "AE"), is any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have to have a causal relationship with the treatment. Amgen staff are required to report AEs within one business day of learning of the AE.
We are committed to the ethical and responsible treatment of all animals used in the discovery and development of medicines to fight serious illnesses in humans such as cancer, kidney disease, neurologic disorders and inflammatory diseases.
Amgen periodically monitors the information contained in CMS-Recognized Compendia and submits corrections or updates as necessary.
Amgen staff and their representatives in the Global Research and Development organization are not permitted to provide gifts of any nature to healthcare professionals and/or members of the scientific community.